Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families.

Authors:
Maryam Sobhani Mohammad Amin Tabatabaiefar Asadollah Rajab Abdol-Mohammad Kajbafzadeh Mohammad Reza Noori-Daloii

Mol Biol Rep 2014 Nov 31;41(11):7499-505. Epub 2014 Aug 31.

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Poursina Ave, 16 Azar St. Keshavarz BLVD, 1417613151, Tehran, Iran.

Wolfram syndrome also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness) is a rare neurodegenerative autosomal recessive disorder. There is evidence of variable expressivity both in patients and heterozygous carriers. In this study, we describe three Persian Wolfram syndrome families with differences in the age of onset, signs and symptoms of the disease. We clinically evaluated affected families for verifying WS clinical diagnosis. After linkage analysis via 5 STR markers, molecular analysis for WFS1 was performed by direct sequencing for patients and available family members. Three homozygous mutations were identified including c.1885 C>T, c.2205C>A both in exon 8 and c.460+1G>A in intron 4. The mutation c.2205C>A was found to be novel. We report interesting phenotype-genotype correlations: homozygous c.1885C>T and c.2205C>A variants were correlated with quite different disease severity and onset in the siblings. We report a rare case of WS with homozygous c.1885C>T who is married and has a healthy child. c.460+1G>A showed a possible partial dominant inheritance put forth by a heterozygous parent showing partial WS symptoms while her daughter displayed typical WS symptoms. Due to variable expressivity, detailed clinical examination and molecular diagnostics should be used to confirm WS and a more exact recurrence risk data.

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11033-014-3642
Web Search
http://link.springer.com/10.1007/s11033-014-3642-3
Publisher Site
http://dx.doi.org/10.1007/s11033-014-3642-3DOI Listing
November 2014

Publication Analysis

Top Keywords

wolfram syndrome
12
variable expressivity
8
homozygous c1885c>t
8
c2205c>a exon
4
c>t c2205c>a
4
c1885 c>t
4
identified including
4
homozygous mutations
4
mutations identified
4
exon c460+1g>a
4
including c1885
4
c460+1g>a intron
4
interesting phenotype-genotype
4
phenotype-genotype correlations
4
correlations homozygous
4
report interesting
4
novel report
4
intron mutation
4
mutation c2205c>a
4
c2205c>a novel
4

Similar Publications

Deficiency of WFS1 leads to the impairment of AVP secretion under dehydration in male mice.

Authors:
Junki Kurimoto Hiroshi Takagi Takashi Miyata Yuichi Hodai Yohei Kawaguchi Daisuke Hagiwara Hidetaka Suga Tomoko Kobayashi Mariko Sugiyama Takeshi Onoue Yoshihiro Ito Shintaro Iwama Ryoichi Banno Katsuya Tanabe Yukio Tanizawa Hiroshi Arima

Pituitary 2021 Mar 5. Epub 2021 Mar 5.

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Wolfram syndrome (WS) is mainly caused by mutations in the WFS1 gene and characterized by diabetes mellitus, optic atrophy, hearing loss, and central diabetes insipidus (CDI). WFS1 is an endoplasmic reticulum (ER)-resident transmembrane protein, and Wfs1 knockout (Wfs1-/-) mice, which have been used as a mouse model for WS, reportedly manifested impairment of glucose tolerance due to pancreatic β-cell loss. In the present study, we examined water balance, arginine vasopressin (AVP) secretion, and ER stress in AVP neurons of the hypothalamus in Wfs1-/- mice. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Etiologic distribution and clinical characteristics of pediatric diabetes in 276 children and adolescents with diabetes at a single academic center.

Authors:
Ja Hye Kim Yena Lee Yunha Choi Gu-Hwan Kim Han-Wook Yoo Jin-Ho Choi

BMC Pediatr 2021 Mar 4;21(1):108. Epub 2021 Mar 4.

Department of Pediatrics, Medical Genetics Center, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.

Background: The prevalence of monogenic diabetes is estimated to be 1.1-6.3% of patients with diabetes mellitus (DM) in Europe. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Behavioral characterization of a novel Cisd2 mutant mouse.

Authors:
Christiann H Gaines Angela E Snyder Robin B Ervin Joseph Farrington Kenneth Walsh Sarah A Schoenrock Lisa M Tarantino

Behav Brain Res 2021 Feb 18;405:113187. Epub 2021 Feb 18.

Department of Genetics, University of North Carolina at Chapel Hill, NC, United States; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, United States. Electronic address:

Wolfram syndrome (WFS) is a rare autosomal recessive disorder characterized by diabetes mellitus and insipidus, progressive optic atrophy and sensorineural deafness. An increased incidence of psychiatric disorders has also been reported in WFS patients. There are two subtypes of WFS. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A revealing flaw.

Authors:
Mitch Leslie

Science 2021 Feb;371(6530):663-665

View Article and Full-Text PDF
February 2021
Similar Publications

Discovering symptom patterns of COVID-19 patients using association rule mining.

Authors:
Meera Tandan Yogesh Acharya Suresh Pokharel Mohan Timilsina

Comput Biol Med 2021 Feb 1;131:104249. Epub 2021 Feb 1.

Data Science Institute, Insight Centre for Data Analytics, National University of Ireland Galway, Ireland. Electronic address:

Background: The COVID-19 pandemic is a significant public health crisis that is hitting hard on people's health, well-being, and freedom of movement, and affecting the global economy. Scientists worldwide are competing to develop therapeutics and vaccines; currently, three drugs and two vaccine candidates have been given emergency authorization use. However, there are still questions of efficacy with regard to specific subgroups of patients and the vaccine's scalability to the general public. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap